NVP-2 is an effective and selective ATP-competitive cyclin-dependent kinase 9 (CDK9) probe. NVP-2 induces cell apoptosis. NVP-2 inhibits CDK9/CycT activity (IC50: 0.514 nM). NVP-2 shows inhibitory effcts on CDK1/CycB, CDK2/CycA and CDK16/CycY kinases (IC50: 0.584 μM, 0.706 μM, and 0.605 μM, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 137 | |
2 mg | In stock | $ 232 | |
4 mg | In stock | $ 416 | |
10 mg | In stock | $ 726 | |
20 mg | In stock | $ 1139 |
Description | NVP-2 is an effective and selective ATP-competitive cyclin-dependent kinase 9 (CDK9) probe. NVP-2 induces cell apoptosis. NVP-2 inhibits CDK9/CycT activity (IC50: 0.514 nM). NVP-2 shows inhibitory effcts on CDK1/CycB, CDK2/CycA and CDK16/CycY kinases (IC50: 0.584 μM, 0.706 μM, and 0.605 μM, respectively). |
Targets&IC50 | CDK9: 0.5 nM (IC50) |
CAS No. | 1263373-43-8 |
Chemical Formula | C27H37ClN6O2 |
Molecular Weight | 513.08 |
Solubility | DMSO: 100 mg/mL (194.91 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom